Faecal microbial transplantation (FMT) was pioneered as a licenced medicine by Professor Hawkey and his team at the University of Birmingham
An innovative treatment for patients with Clostridium difficile infection (CDI) which uses transplanted gut bacteria to treat the infection, is a more effective and more cost-efficient treatment than using antibiotics, a new UK study has found.
CDI is an infection of the bowel, which commonly affects people who have recently been treated in hospital, those with underlying conditions and patients over 65. Almost 30 per cent of patients treated for the condition experience at least one recurrence. A recurrence of the condition, has been associated with a higher risk of mortality and is usually treated using antibiotics.
Faecal microbial transplantation (FMT), a treatment pioneered as a licenced medicine by Professor Peter Hawkey and his team at the University of Birmingham, is a method where gut bacteria and other components in faeces are used to treat CDI. The bacteria is taken from a screened healthy donor, processed and screened before being transplanted via a tube passed through the nose into the stomach. Treatment with FMT is associated with higher cure and lower recurrence rates than fidaxomicin or vancomycin- the two most common antibiotics used to treat recurrent CDI (rCDI).
The study, which presents the first decision model for patients with rCDI already hospitalised in the UK, analysed randomised controlled trials, observational studies and expert opinion from the UK, on patients with single or multiple rCDI. Researchers analysed the cost of each of the four treatment options for rCDI for treatment effects, unit costs, resource and health related quality of life to identify which treatment was the most cost-effective and offered the best outcome for patients.
The study showed that both methods for administering FMT were lower in cost compared to standard treatment with antibiotics. FMT via naso-gastric tube was the least costly, with a mean cost of £8,877 per patient, while FMT via colonoscopy was £11,716 per patient. FMT via colonoscopy was also shown to be slightly more effective than treatment via naso-gastric tube, offering patients a higher quality of life. Two other standard antibiotic treatments vancomycin and fidaxomicin were compared in the model but both these treatments were shown to be more costly and less effective than either of the FMT interventions. Moreover, Vancomycin was the most expensive and the least effective treatment.
Professor Peter Hawkey, formerly of the University of Birmingham said, “We at the University of Birmingham pioneered this treatment as the UK’s first third party FMT service. FMT is not currently a widespread treatment for this disease but by showing that it not only saves lives, but is also significantly more cost effective, we hope that this could be one of the first steps towards the treatment being accepted more widely.”
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Clostridium difficile infection
- What to know about food poisoning
These are usually viruses, bacteria, or parasites. When the source of such infection is food, it is called food poisoning. The onset of gastroenteritis symptoms after eating food affected by a ...
- Nestle crunch: Seres’ bar for Vowst sales within grasp?
About a year ago, when Seres Therapeutics Inc. won U.S. FDA approval of oral microbiome therapy Vowst (live fecal microbiota spores), the drug – meant to prevent recurrent Clostridium difficile ...
- How Peoria-area hospitals rate when it comes to safety, patient care, according to report
Methodist ranked highly on dealing with MRSA and urinary tract infections, in preventing surgical problems such as leaving dangerous objects in the body, keeping splits closed, blood leakage, ...
- Everything You Need to Know About C. diff
diff is short for Clostridium difficile, an infectious bacterium ... diff under control. A C. diff infection occurs when there’s too much of the bacterium in your intestines.
- Treatment for Deadly Superbug C. diff May Be Weakening
The antibiotic vancomycin, recommended as first-line treatment for infection caused by the deadly superbug C. difficile (C. diff), may not be living up to its promise, according to new research from ...
Go deeper with Google Headlines on:
Clostridium difficile infection
[google_news title=”” keyword=”Clostridium difficile infection” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Faecal microbial transplantation
- Intestine Transplantation
The international experience of small bowel transplantation since 1985 has been compiled and analyzed through the International Intestinal Transplant Registry. [10] As of May 2001, the Registry ...
- Poo transplant researchers are trying to manufacture the 'ultimate' gut microbiome
Matthew donates poo to his local stool bank to help treat gut diseases. In the future, faecal transplants may use gut bacteria grown in the lab, not in humans.
- Liver Transplant News and Research
Liver transplantation is a life-saving option for those with hepatocellular carcinoma (HCC), the most prevalent type of liver cancer. A type of cell responsible for repairing damaged liver tissue ...
- Microbes and More News
The team's experiments show that the two microbial species have developed a coordinated ...
- Surgeons Perform World’s First Combined Heart Pump And Pig Kidney Transplant—Latest Breakthrough Involving Pig Organ
Surgeons at NYU Langone Health announced Wednesday they completed the world’s first successful combined heart pump and gene-edited pig kidney transplant surgeries on a 54-year-old woman with end ...
Go deeper with Google Headlines on:
Faecal microbial transplantation
[google_news title=”” keyword=”faecal microbial transplantation” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]